I have a Freedom of Information request regarding Multiple Sclerosis – in your organisation, how many patients with Multiple Sclerosis have been treated with MS disease modifying drugs in the past 12 months?

1. Please provide the number of patients by treatment for the following drugs:
Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Ampyra (Fampyra)
Peginterferon beta-1a

Download response Multiple Sclerosis 240915